Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening
Article in Anticancer Research (May 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
Article in Frontiers in Oncology (March 2023)
N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy
Article in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (February 2023)